Simon Melov

Simon Melov

Auto-generated profile, based on publicly available information

Simon Melov

Buck Institute for Research on Aging Novato California USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JFJames M. Flynn
James M. Flynn
SMSimon Melov
Simon Melov

1 September 2011 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
JCJudith Campisi
Judith Campisi
JAJulie K. Andersen
Julie K. Andersen
PKPankaj Kapahi
Pankaj Kapahi
SMSimon Melov
Simon Melov

4 June 2013 in Aging Cell
Verified
Journal Article
Open access
PDF file
JFJames M. Flynn
James M. Flynn
MOMonique N. O'Leary
Monique N. O'Leary
CZChristopher A. Zambataro
Christopher A. Zambataro
EAEmmeline C. Academia
Emmeline C. Academia
MPMichael P. Presley
Michael P. Presley
SMSimon Melov
Simon Melov
Rapamycin has been shown to extend lifespan in numerous model organisms including mice, with the most dramatic longevity effects reported in females. However, little is known about the functional ramifications of this longevity‐enhancing paradigm in mammalian tissues. We treated 24‐month‐old female C57BL/6J mice with rapamycin for 3 months and determined health outcomes via a variety of noninvasive measures of cardiovascular, skeletal, and metabolic health for individual mice. We determined that while rapamycin has mild transient metabolic effects, there are significant benefits to late‐life cardiovascular function with a reversal or attenuation of age‐related changes in the heart. RNA‐seq analysis of cardiac tissue after treatment indicated inflammatory, metabolic, and antihypertrophic expression changes in cardiac tissue as potential mechanisms mediating the functional improvement. Rapamycin treatment also resulted in beneficial behavioral, skeletal, and motor changes in these mice compared with those fed a control diet. From these findings, we propose that late‐life rapamycin therapy not only extends the lifespan of mammals, but also confers functional benefits to a number of tissues and mechanistically implicates an improvement in contractile function and antihypertrophic signaling in the aged heart with a reduction in age‐related inflammation.

23 May 2007 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SMSimon Melov
Simon Melov
mark tarnopolskymark tarnopolsky
mark tarnopolsky
KBKenneth Beckman
Kenneth Beckman
KFKrysta Felkey
Krysta Felkey
AHAlan Hubbard
Alan Hubbard
Human aging is associated with skeletal muscle atrophy and functional impairment (sarcopenia). Multiple lines of evidence suggest that mitochondrial dysfunction is a major contributor to sarcopenia. We evaluated whether healthy aging was associated with a transcriptional profile reflecting mitochondrial impairment and whether resistance exercise could reverse this signature to that approximating a younger physiological age. Skeletal muscle biopsies from healthy older (N = 25) and younger (N = 26) adult men and women were compared using gene expression profiling, and a subset of these were related to measurements of muscle strength. 14 of the older adults had muscle samples taken before and after a six-month resistance exercise-training program. Before exercise training, older adults were 59% weaker than younger, but after six months of training in older adults, strength improved significantly (P<0.001) such that they were only 38% lower than young adults. As a consequence of age, we found 596 genes differentially expressed using a false discovery rate cut-off of 5%. Prior to the exercise training, the transcriptome profile showed a dramatic enrichment of genes associated with mitochondrial function with age. However, following exercise training the transcriptional signature of aging was markedly reversed back to that of younger levels for most genes that were affected by both age and exercise. We conclude that healthy older adults show evidence of mitochondrial impairment and muscle weakness, but that this can be partially reversed at the phenotypic level, and substantially reversed at the transcriptome level, following six months of resistance exercise training.

19 November 2002 in Aging Cell
Verified
Journal Article
Open access
PDF file
TGTamara R. Golden
Tamara R. Golden
DHDouglas A. Hinerfeld
Douglas A. Hinerfeld
SMSimon Melov
Simon Melov
Summary: The oxidative stress theory of aging has become increasingly accepted as playing a role in the aging process, based primarily on a substantial accumulation of circumstantial evidence. In recent years, the hypothesis that mitochondrially generated reactive oxygen species play a role in organismal aging has been directly tested in both invertebrate and mammalian model systems. Initial results imply that oxidative damage, specifically the level of superoxide, does play a role in limiting the lifespans of invertebrates such as Drosophila melanogaster and Caenorhabditis elegans. In mammalian model systems, the effect of oxidative stress on lifespan is less clear, but there is evidence that antioxidant treatment protects against age‐related dysfunction, including cognitive decline.

1 November 2001 in The Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
SMSimon Melov
Simon Melov
SDSusan R. Doctrow
Susan R. Doctrow
JSJulie A. Schneider
Julie A. Schneider
JHJoanna Haberson
Joanna Haberson
MPManisha Patel
Manisha Patel
BMBernard Malfroy
Bernard Malfroy
Superoxide is produced as a result of normal energy metabolism within the mitochondria and is scavenged by the mitochondrial form of superoxide dismutase (sod2). Mice with inactivated SOD2 (sod2 nullizygous mice) die prematurely, exhibiting several metabolic and mitochondrial defects and severe tissue pathologies, including a lethal spongiform neurodegenerative disorder (Li et al., 1995; Melov et al., 1998, 1999). We show that treatment ofsod2 nullizygous mice with synthetic superoxide dismutase (SOD)–catalase mimetics extends their lifespan by threefold, rescues the spongiform encephalopathy, and attenuates mitochondrial defects. This class of antioxidant compounds has been shown previously to extend lifespan in the nematode Caenorhabditis elegans (Melov et al., 2000). These new findings in mice suggest novel therapeutic approaches to neurodegenerative diseases associated with oxidative stress such as Friedreich ataxia, spongiform encephalopathies, and Alzheimer9s and Parkinson9s diseases, in which chronic oxidative damage to the brain has been implicated.